ASPM and pancreatic neoplasm: High levels of expression of ASPM (p = 0.0039), TOP2A (p = 0.038), DLGAP5 (p = 0.0019), TPX2 (p = 0.00036), KIF23 (p = 0.0034), MELK (p = 0.022), LAMA3 (p = 0.00044), and ANLN (p = 0.015) were significantly correlated with the OS of patients with pancreatic cancer, while CENPF (p = 0.13) and LAMC2 (p = 0.19) expression were not relevant to survival, as shown in Figure 7B.